Prenua add new health tests to full body scan, a new financing round

The pre -harmful health startup announced Thursday that it will offer three new health evaluations in addition to its flagship magnetic resonance exploration.

The company is launching a detailed blood analysis, neurological exploration and body composition analysis that was approved by the United States Food and Medicines Administration in recent weeks. Prenuo said that he wants to give customers a precise image of his health, and that his patients have been asking for more.

“They have reached the understanding and realization that the health system is not satisfying their needs in regards to keep them healthy,” said the Prenuo CEO, Andrew Lacy, CNBC in an interview. “Consumers are increasingly looking for alternative solutions so that they can stay aware of their health.”

Prenua exploded in popularity due to its full -body magnetic resonance exploration of $ 2,500 that has been praised by celebrities such as Kim Kardashian. The company can verify hundreds of conditions such as cancer, multiple sclerosis and aneurysms once its personalized magnetic resonance machines approved by the FDA scan a person's body in an hour.

Complete body exploration and the new blood test analysis, neurological exploration and body composition will be packaged and clients will be offered for $ 3,999, Lacy said.

Prenu has exceeded 110,000 members, and the company generated $ 100 million in revenue last year. It owns and operates 17 clinics in North America and plans to expand to 15 more locations in the coming months, including sites in Europe and Australia, Lacy said.

Lacy said Prenuo has grown rapidly but is profitable.

Prenu has faced criticism for their precious prices, and some medical experts have warned that scannings are not destined to replace directed exams and could make patients seek unnecessary care.

Investors are optimistic anyway.

The company announced Thursday that it closed a financing round of $ 120 million, directed by Left Lane Capital, Forerunner Ventures and its existing investor, Felicis. He pretended to use his new financing to support the expansion of his product, his impulse in new regions and explore applications for artificial intelligence.

A full -body magnetic resonance startup announced a financing round of $ 21 million last February.

Lacy said Prenua has the largest repository of magnetic resonance images of the whole body in the world, which means that there are many opportunities for the company to build models that make its exams more precise and its 80 radiologists certified by the Board be more efficient.

The new body composition analysis of the company, which is called the Prenuo Body Composition Report, uses AI to assess the volume and symmetry of the muscles and the distribution of fat in the abdomen. Lacy said that size and muscle distribution is a main mobility indicator, and fat distribution can affect the risk of metabolic disease and cardiovascular disease.

“This is very, very important information for patients who seek to proactively administer their health,” Lacy said.

Patients will not need to undergo an additional image for the Prenuo Body Composition Report.

The new health exploration of the Prenua brain is also based on images, and gives patients an idea of ​​their health and cognitive function, said the company. The exploration uses neurological sequences through a prenu partner to evaluate blood flow, the microvascular structure of the brain and identify any repetitive trauma of the activity such as sports.

It requires additional 10 minutes of image, and the sequences are already approved by the FDA, Lcy said.

Blood evaluation is a new territory for the company, and will verify the biomarkers of patients who provide information on hormonal, cardiovascular, metabolic and immune health. Lacy said the test could help detect leukemia, blood cancer that cannot be identified with images, for example.

“Blood and images together are incredibly powerful,” Lacy said. “It is not a case of one plus one is equal to two, it is one more one is equal to five.”

Initially, a phlebotomist, a person trained to extract blood, will reach patients' homes to collect the blood sample, prenu said. The company also plans to extract blood within its facilities eventually, but LACY wants to provide a premium experience that is as relaxing and comfortable as possible.

Patients can access the new evaluations in the locations of Silicon Valley, Los Angeles and New York starting Thursday. Additional locations will offer this spring, the company said.

“No one will care about your health more than you,” Lacy said. “When you diagnose things early, it's empowering. You can do something about it.”

Correction: Due to an incorrection of the company, a previous version of this story incorrectly attributed the development of neurological sequence technology to prenu.

Look: John Hancock's CEO speaks of collaboration with prenualized and focuses on longevity